Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details)

v3.19.1
Note 9 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
Details    
Real estate note $ 110,589 $ 111,843
Working capital note 930,793 909,507
Impairment recorded (992,114) 0
Note receivable discount 0 (7,591)
Accrued interest 0 3,067
Less current portion (49,268) (45,173)
Long term portion of notes receivable $ 0 $ 971,653